Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
Business & Industry
- Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease
- Pfizer begins a Phase 1/2 study to evaluate respiratory syncytial virus (RSV) vaccine
- Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer
- Novo Nordisk increases commitment to stem cell-based therapies
- Sanofi and Ablynx announce the successful results of the initial tender offer period
Research & Development
- Antidepressant use may contribute to long-term population weight gain
- Study demonstrates new treatment for severe asthma
- Eczema drug effective against severe asthma
- Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
- Doctors in US and Canada launch sweeping pharmaceutical reform proposal
- Stroke prevention drug combo shows promise
- First clues to the causes of multiple sclerosis
Conferences & Events
- SMi presents the launch of Cell & Gene Therapy 2018
- SMi presents the 9th Conference on Biosimilars & Biobetters
- SMi presents the 13th Conference on ADMET
- SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast
- Introducing SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology this June 2018
- Adaptive Designs in Clinical Trials Conference 2018
- Drug Safety 2018
Regulatory Affairs
- FDA approves novel preventive treatment for migraine
- FDA approves first epoetin alfa biosimilar for the treatment of anemia
- FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients
- FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
- FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
- FDA approves new treatment for certain digestive tract cancers
- FDA approves first treatment for breast cancer with a certain inherited genetic mutation